Ceftriaxone and Dextrose in Duplex Container
Categoria
Ceftriaxone and Dextrose in Duplex Container Marchi, Ceftriaxone and Dextrose in Duplex Container Analoghi
Ceftriaxone and Dextrose in Duplex Container Marchi miscela
Ceftriaxone and Dextrose in Duplex Container Formula chimica
C18H18N8O7S3
Ceftriaxone and Dextrose in Duplex Container RX link
http://www.rxlist.com/cgi/generic3/ceftriax.htm
Ceftriaxone and Dextrose in Duplex Container FDA foglio
Ceftriaxone and Dextrose in Duplex Container DMS (foglio di materiale di sicurezza)
Ceftriaxone and Dextrose in Duplex Container Sintesi di riferimento
M. Montavon, R. Reiner, Brit. pat. Appl. 2.022.090; eidem, US Pat. 4.327.210 (1979, 1982 sia per Hoffmann-La Roche)
Ceftriaxone and Dextrose in Duplex Container Peso molecolare
554.583 g/mol
Ceftriaxone and Dextrose in Duplex Container Temperatura di fusione
>155 oC
Ceftriaxone and Dextrose in Duplex Container H2O Solubilita
Nessuna informazione disponibile
Ceftriaxone and Dextrose in Duplex Container Stato
Solid
Ceftriaxone and Dextrose in Duplex Container LogP
-1.341
Ceftriaxone and Dextrose in Duplex Container Forme di dosaggio
IM infusione;
Ceftriaxone and Dextrose in Duplex Container Indicazione
Per il trattamento delle infezioni (respiratorie, della pelle, dei tessuti molli, UTI, ORL) causate da S. pneumoniae, H. influenzae, stafilococchi, S. pyogenes (gruppo A beta-emolitico di streptococchi), E. coli, P. mirabilis, Klebsiella sp, stafilococco coagulasi-negativi
Ceftriaxone and Dextrose in Duplex Container Farmacologia
Ceftriaxone è una cefalosporina / cephamycin beta-lattamici antibiotici utilizzati nel trattamento delle infezioni batteriche causate da sensibili, di solito gram-positivi, organismi. Ceftriaxone ha attività in vitro contro i batteri aerobi e anaerobi Gram-positivi e gram-negativi. L'attività battericida dei risultati Ceftriaxone dalla inibizione della sintesi della parete cellulare ed è mediata da Ceftriaxone vincolante legame alle proteine penicillina (PBP). Ceftriaxone è stabile contro idrolisi da una varietà di beta-lattamasi, incluse penicillinasi, e cefalosporinasi ed esteso spettro beta-lattamasi.
Ceftriaxone and Dextrose in Duplex Container Assorbimento
Nessuna informazione disponibile
Ceftriaxone and Dextrose in Duplex Container Tossicita
Nessuna informazione disponibile
Ceftriaxone and Dextrose in Duplex Container Informazioni paziente
Patient Information:
Patients should be counseled that antibacterial drugs including Ceftriaxone should only be used to
treat bacterial infections. They do not treat viral infections (eg, common cold). When Ceftriaxone
is prescribed to treat a bacterial infection, patients should be told that although it is common
to feel better early in the course of therapy, the medication should be taken exactly as directed.
Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of
the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and
will not be treatable by Ceftriaxone or other antibacterial drugs in the future.
Patients should be counseled that antibacterial drugs including Ceftriaxone should only be used to
treat bacterial infections. They do not treat viral infections (eg, common cold). When Ceftriaxone
is prescribed to treat a bacterial infection, patients should be told that although it is common
to feel better early in the course of therapy, the medication should be taken exactly as directed.
Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of
the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and
will not be treatable by Ceftriaxone or other antibacterial drugs in the future.
Ceftriaxone and Dextrose in Duplex Container Atto interessato organismi
Batteri enterici e altri eubatteri
